Home › Funds › ACUTA CAPITAL PARTNERS, LLC › AMLX

ACUTA CAPITAL PARTNERS, LLC position in AMLX

AMYLYX PHARMACEUTICALS INC · Health Care

ACUTA CAPITAL PARTNERS, LLC reported holding 62,956 shares of AMLX (AMYLYX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$1.8M, representing 1.45% of its reported portfolio and ranking #20 among its reported holdings. ACUTA CAPITAL PARTNERS, LLC has disclosed AMLX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)62.96K sh
Reported value held$1.83M
Portfolio Weight1.45%
First reportedQ3 2025
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How ACUTA CAPITAL PARTNERS, LLC's AMLX position evolved

ACUTA CAPITAL PARTNERS, LLC first disclosed a stake in AMLX in Q3 2025 at 333,258 shares (US$4.5M). Across 5 filings, ACUTA CAPITAL PARTNERS, LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 62,956 shares valued at US$1.8M — a reduction of -105,159 shares quarter over quarter.. Notable position changes include a 55% trim in Q1 2026 (shares rose 29% over the following quarter), a 63% trim in Q3 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 333.26K $4.53M New
Q4 2025 333.26K $4.03M Hold
Q1 2026 151.07K $2.10M Reduce
Q2 2026 168.12K $3.02M Add
Q3 2026 62.96K $1.83M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AMLX and 13F data

AMLX (AMYLYX PHARMACEUTICALS INC) is a Health Care company. 47 other funds we track also report a position in AMLX — the largest reported positions include TCG Crossover Management, LLC (US$181.7M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$158.0M), PERCEPTIVE ADVISORS LLC (US$149.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AMLX

All AMLX fund holders →

FAQ

How long has ACUTA CAPITAL PARTNERS, LLC held AMLX?

ACUTA CAPITAL PARTNERS, LLC has disclosed AMLX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is ACUTA CAPITAL PARTNERS, LLC's current position in AMLX?

As of Q3 2026, ACUTA CAPITAL PARTNERS, LLC holds 62.96K shares of AMLX (AMYLYX PHARMACEUTICALS INC), valued at $1.83M, representing 1.45% of its reported portfolio and ranking #20.

Has ACUTA CAPITAL PARTNERS, LLC been buying or selling AMLX?

In the latest 13F filing (Q3 2026), ACUTA CAPITAL PARTNERS, LLC reduced its position in AMLX.

Which other funds hold AMLX?

Other major institutional holders of AMLX include TCG Crossover Management, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, PERCEPTIVE ADVISORS LLC, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.